ReAlta Life Sciences To Receive a Commonwealth Research Commercialization Fund (CRCF) Grant

ReAlta Life Sciences is pleased to have received a Commonwealth Research Commercialization Fund (CRCF) grant. This award will help support the clinical development of ReAlta’s lead compound (PIC1 / RLS-0071) to treat babies suffering hypoxic ischemic encephalopathy, a severe form of birth asphyxia.

https://www.cit.org/crcf-award-recipients.html

Loading...